Boronate Affinity Tests Market Report 2026

The boronate affinity tests market size has grown strongly in recent years. It will grow from $3.81 billion in 2025 to $4.19 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of diabetes diagnostics, expansion of proteomics research activities, growing pharmaceutical R&D investments, adoption of affinity chromatography techniques, increased use of biomarker-based testing.

The boronate affinity tests market size is expected to see strong growth in the next few years. It will grow to $6.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising adoption of automated laboratory workflows, growing focus on early disease detection, expansion of personalized medicine research, increasing integration of advanced analytical platforms. Major trends in the forecast period include increasing adoption of boronate-based glycoprotein analysis, rising demand for high-specificity affinity assays, growing use of automated boronate affinity instruments, expansion of drug discovery applications, enhanced focus on high-throughput testing.

The growing diabetic population is expected to drive the expansion of the boronate affinity tests market in the coming years. Diabetes is a chronic health condition marked by elevated blood glucose levels due to the body's inability to produce or efficiently use insulin. The rise in diabetes cases is linked to poor dietary habits, particularly high intake of processed foods and sugary beverages, as well as sedentary lifestyles with limited physical activity. Additionally, factors such as an aging population and a family history of diabetes contribute to increased risk, indicating a genetic predisposition. Boronate affinity tests are utilized in diabetes management to precisely measure glycated proteins, offering a dependable indicator of long-term blood glucose control. For example, in June 2023, data published by The Lancet, a UK-based book and periodical data publishing organization, projected that global diabetes cases would reach 1.3 billion by 2050. Consequently, the rising diabetic population is expected to fuel the growth of the boronate affinity tests market.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the boronate affinity tests market in the coming years. Personalized medicine tailors healthcare based on individual genetic, environmental, and lifestyle factors to enhance treatment outcomes. This increasing focus is supported by improved understanding of genetic variations and their impact on health, along with advancements in diagnostic technologies and progress in data analysis, bioinformatics, and precision medicine tools. Boronate affinity tests play a role in personalized medicine by enabling accurate monitoring of glycation levels in patients, supporting customized diabetes management and treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Among these, seven drugs were specifically designed for cancer treatment, and three targeted other diseases and conditions. Consequently, the rising focus on personalized medicine is expected to propel the growth of the boronate affinity tests market.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical technology company, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed sum. The acquisition aims to strengthen Mindray's global presence in the in vitro diagnostics (IVD) sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. DiaSys Diagnostic Systems GmbH, based in Germany, manufactures diagnostic systems, including HbA1c analyzers that utilize boronate affinity chromatography.

Major companies operating in the boronate affinity tests market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Merck KGaA, Tosoh Corporation, Agilent Technologies Inc, Bio-Rad Laboratories Inc, ARKRAY Inc, EKF Diagnostics Holdings plc, Trinity Biotech, SeraCare Life Sciences Inc, Medix Biochemica, Biosynth, Santa Cruz Biotechnology, A Menarini Diagnostics Srl, Diazyme Laboratories Inc, Bioventix PLC, GenWay Biotech Inc, Alere Inc, Green Cross Holdings Corp., HemoCue AB, PTS Diagnostics, Diatheva, OSANG Healthcare Co Ltd, Cypress Diagnostics, Goldsite Diagnostics Inc.

North America was the largest region in the boronate affinity tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the boronate affinity tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the boronate affinity tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the boronate affinity tests market by increasing costs of imported analytical instruments, specialty reagents, resin columns, and precision laboratory components used in diagnostics and research applications. Research institutes and pharmaceutical companies in North America and Europe are most affected due to reliance on imported high-purity materials and testing systems, while Asia-Pacific faces higher costs in instrument procurement. These tariffs are raising operational expenses and slowing laboratory upgrades. However, they are also encouraging localized reagent manufacturing, regional instrument assembly, and domestic innovation in affinity-based testing solutions.

The boronate affinity tests market research report is one of a series of new reports that provides boronate affinity tests market statistics, including boronate affinity tests industry global market size, regional shares, competitors with a boronate affinity tests market share, detailed boronate affinity tests market segments, market trends and opportunities, and any further data you may need to thrive in the boronate affinity tests industry. This boronate affinity tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Boronate affinity tests are employed to examine the interactions between boron-containing compounds and molecules that possess diol or other cis-diol functional groups. These tests utilize the distinctive ability of boronate esters to form reversible covalent bonds with diol groups, making them valuable for applications such as protein and carbohydrate analysis, as well as drug development.

The primary product types of boronate affinity tests include test kits, instruments, and consumables. Test kits for boronate affinity tests are pre-assembled sets containing all the necessary reagents and materials to conduct the test, designed to detect specific compounds, such as glycated proteins, using boronate affinity technology. The technologies are divided into fluorescence-based tests, colorimetric assays, and electrochemical methods for applications such as type 1 diabetes and type 2 diabetes. The end users comprise hospitals and clinics, diagnostic laboratories, research institutes, and pharmaceutical and biotechnology companies.

The boronate affinity tests market consists of revenues earned by entities by providing services such as glycoprotein and carbohydrate detection, glycosylation pattern analysis, and biomolecule isolation using boronic acid derivatives. The market value includes the value of related goods sold by the service provider or included within the service offering. The boronate affinity tests market also includes sales of boronate affinity columns, boronate affinity resins, boronate affinity kits, detection reagents, assay plates, instrumentation and calibration standards. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.